A recent study assessed the coronary arteries of 63 hearts obtained from fetuses (n ¼ 20), infants up to 1 year old (n ¼ 18), children aged 1 to 11 years (n ¼ 15), and adolescents aged 11 to 18 years (n ¼ 10) who had died from noncardiac disease or trauma. 1 Coronary intimal thickening was found in 10% of fetuses, a third of the infants, 73.3% of the children and virtually all the adolescents. It was concluded that intimal thickening begins already in fetal life and progresses through childhood and adolescence. 1 Predisposition to coronary heart disease (CHD) may already exist not only in infancy but even in utero. In the late 1980s, a study from Finland assessed the coronary arteries of 94 infants aged < 1 year who died in hospital and 102 children 1 to 16 year old who died accidentally. 2 The mean degree of narrowing in the left coronary artery during the first year of life was 17%. In children > 1 year old, the mean narrowing was 25% while in children between 12 and 15 years, it was 34%. 2 The same group subsequently evaluated the coronary arteries of low-birthweight infants (n ¼ 111) who died within 30 days after birth (median: postnatal day 6). 3 The gestational age of these infants varied between 23 and 42 weeks (mean: 35 weeks). Coronary intimal thickness had a strong positive correlation with gestational age (r ¼ 0.504; P < .0001) and birthweight (r ¼ 0.514; P < .0001). 3 In the early 1990s, Barker formulated the so-called "Fetal Origins of Adult Disease" or "The Barker Hypothesis," according to which the pathogenesis of CHD begins in utero. 4 Barker and his group showed that babies who are small at birth or in infancy have high rates of CHD, stroke, hypertension, and diabetes in adult life. 4,5 This effect is not confined to babies with intrauterine growth restriction (defined as birth weight 10th customized centile for gestational age) but is also seen in infants born with average birth weight, which are, however, followed by below-average weight gain. He proposed that for several individuals, CHD and other diseases may be programmed already in utero. 4, 5 We recently evaluated potential prognostic biomarkers for cardiovascular disease in large-for-gestational-age (LGA) compared with appropriate-for-gestational-age (AGA) neonates. 6 Cardiotrophin-1 (a cardiomyocyte-produced chemokine) and titin (a protein in the sarcomere of cardiac myocytes) concentrations were higher in LGA compared with AGA neonates (P < .001 and P ¼ .023, respectively).
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A subgroup analysis in the LGA group showed that increased cardiotrophin-1 levels were observed only in diabetic pregnancies. It was concluded that both cardiotrophin-1 and titin concentrations could represent prognostic biomarkers for future cardiovascular disease. 6 Coronary intimal thickening indeed begins in utero and progresses in infancy and childhood. Future studies should search for reliable biomarkers which could help identify those infants/ children at higher than average future CHD risk and implement primary prevention strategies (eg, lifestyle measures like weight loss, exercise, and a healthy diet) early in life. Early pharmacotherapy will need a further level of evidence.
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